Study Of KITE-753 in R/R B-Cell ALL

NCT07674823 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

18

Enrollment

OTHER

Sponsor class

Conditions

B-cell Acute Lymphoblastic Leukemia

Interventions

DRUG: KITE-753

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]